Ignite Creation Date:
2025-12-24 @ 12:43 PM
Ignite Modification Date:
2026-03-01 @ 2:44 AM
Study NCT ID:
NCT06977061
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-05-16
First Post:
2025-04-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression
Sponsor:
Queling Liu
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-09-01
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-30
First Submit QC Date:
None
Study First Post Date:
2025-05-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-10
Last Update Post Date:
2025-05-16
Last Update Post Date Type:
ACTUAL